Cargando…
Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments
INTRODUCTION: Informed consent forms that restrict the distribution of data and samples have been an impediment to advancing Alzheimer's disease (AD) understandings and treatments. The Coalition Against Major Disease public-private partnership developed concise addenda to responsibly broaden da...
Autores principales: | Hake, Ann M., Dacks, Penny A., Arnerić, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671623/ https://www.ncbi.nlm.nih.gov/pubmed/29124112 http://dx.doi.org/10.1016/j.trci.2017.08.003 |
Ejemplares similares
-
Donor perspectives on informed consent and use of biospecimens for brain organoid research
por: MacDuffie, Katherine E., et al.
Publicado: (2023) -
Responsible sharing of biomedical data and biospecimens via the “Automatable Discovery and Access Matrix” (ADA-M)
por: Woolley, J. Patrick, et al.
Publicado: (2018) -
Secondary consent to biospecimen use in a prostate cancer biorepository
por: Drake, Bettina F., et al.
Publicado: (2016) -
Ethics Reporting in Biospecimen and Genetic Research: Current Practice and Suggestions for Changes
por: Chin, William Wei Lim, et al.
Publicado: (2016) -
To Consent or Not to Consent to Screening, That Is the Question
por: Hofmann, Bjørn
Publicado: (2023)